NUE vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 14, 2026

NUE

60.5
AI Score
VS
NUE Wins

EMR

53.6
AI Score

Investment Advisor Scores

NUE

61score
Recommendation
BUY

EMR

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NUE EMR Winner
Forward P/E 18.2149 21.692 NUE
PEG Ratio 5.2129 1.8061 EMR
Revenue Growth 21.3% 2.9% NUE
Earnings Growth 382.1% 27.9% NUE
Tradestie Score 60.5/100 53.6/100 NUE
Profit Margin 6.8% 13.4% EMR
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD NUE

Frequently Asked Questions

Based on our detailed analysis, NUE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.